​​​

In the Yousefpour Lab, we develop next-generation biomolecular immunotherapies by integrating protein engineering, synthetic biology, and biomaterials to address challenges in cancer and infectious diseases. We engineer RNA- and protein-based platforms to precisely modulate immune responses and improve therapeutic efficacy.

​